WO2005077356A3 - Glycine and/or for use in cartilage affecting conditions - Google Patents
Glycine and/or for use in cartilage affecting conditions Download PDFInfo
- Publication number
- WO2005077356A3 WO2005077356A3 PCT/US2005/004363 US2005004363W WO2005077356A3 WO 2005077356 A3 WO2005077356 A3 WO 2005077356A3 US 2005004363 W US2005004363 W US 2005004363W WO 2005077356 A3 WO2005077356 A3 WO 2005077356A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glycine
- cartilage
- affecting conditions
- cartilage affecting
- flexibility
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
- A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0507486-0A BRPI0507486A (en) | 2004-02-09 | 2005-02-09 | methods for increasing cartilage flexibility in an animal and for strengthening cartilage in an animal, composition for strengthening cartilage in an animal, dog and cat rations, compositions for preventing cartilage abnormalities in an animal and for improving cartilage flexibility in an animal, and method to prevent cartilage degradation in an animal |
AU2005212370A AU2005212370A1 (en) | 2004-02-09 | 2005-02-09 | Glycine and/or for use in cartilage affecting conditions |
CA002554099A CA2554099A1 (en) | 2004-02-09 | 2005-02-09 | Glycine and/or for use in cartilage affecting conditions |
JP2006553259A JP2007522232A (en) | 2004-02-09 | 2005-02-09 | Compositions and methods for use in conditions affecting cartilage |
EP05713355A EP1713464A2 (en) | 2004-02-09 | 2005-02-09 | Glycine and/or proline for use in cartilage affecting conditions |
US11/199,410 US20060029647A1 (en) | 2004-02-09 | 2005-08-08 | Composition and method for use in cartilage affecting conditions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/774,951 | 2004-02-09 | ||
US10/774,951 US20050176807A1 (en) | 2004-02-09 | 2004-02-09 | Composition and method for use in cartilage affecting conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005077356A2 WO2005077356A2 (en) | 2005-08-25 |
WO2005077356A3 true WO2005077356A3 (en) | 2005-12-08 |
Family
ID=34827097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2005/004363 WO2005077356A2 (en) | 2004-02-09 | 2005-02-09 | Glycine and/or for use in cartilage affecting conditions |
Country Status (10)
Country | Link |
---|---|
US (1) | US20050176807A1 (en) |
EP (1) | EP1713464A2 (en) |
JP (1) | JP2007522232A (en) |
CN (1) | CN1917869A (en) |
AU (1) | AU2005212370A1 (en) |
BR (1) | BRPI0507486A (en) |
CA (1) | CA2554099A1 (en) |
RU (1) | RU2006132353A (en) |
WO (1) | WO2005077356A2 (en) |
ZA (1) | ZA200606419B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060029647A1 (en) * | 2004-02-09 | 2006-02-09 | Friesen Kim G | Composition and method for use in cartilage affecting conditions |
EP1789033B1 (en) * | 2004-08-09 | 2019-04-03 | Enrique Melendez Hevia | Glycine as a diet supplement for the treatment of health problems that result from underlying metabolic disorders |
JP2009515953A (en) * | 2005-11-15 | 2009-04-16 | エントレス アーベー | Drugs for use in connection with cartilage disorders |
IT1397522B1 (en) * | 2009-12-21 | 2013-01-16 | Solartium Entpr Ltd | USE OF A COMBINATION FOR THE TREATMENT OF OSTEOARTROSI |
WO2013150292A1 (en) * | 2012-04-02 | 2013-10-10 | Eaglepharma Pty Ltd | Composition for the treatment of inflammatory and immune disorders |
JP2016521289A (en) | 2013-05-14 | 2016-07-21 | マース インコーポレーテッドMars Incorporated | Joint care composition |
CA3078335A1 (en) * | 2017-10-02 | 2019-04-11 | University Of Florida Research Foundation, Incorporated | Materials and methods for inhibiting tumor growth |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB952812A (en) * | 1962-02-01 | 1964-03-18 | Leo Ind Chim Farm Spa | Tetracycline compositions |
US4806525A (en) * | 1987-06-18 | 1989-02-21 | Mavi S.R.L. | Formulation comprising gelatin and glycine for treating the dryness of skin |
US5198465A (en) * | 1991-06-19 | 1993-03-30 | Dioguardi Francesco S | Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen |
EP0652012A1 (en) * | 1989-03-27 | 1995-05-10 | Albert Naito | Combination of sugars with animo acids and other drugs |
US20040092498A1 (en) * | 2002-08-16 | 2004-05-13 | David Blakemore | Substituted glycine derivatives for use as medicaments |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5364845C1 (en) * | 1993-03-31 | 2002-09-10 | Nutramax Lab Inc | Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue |
US6492349B1 (en) * | 1993-03-31 | 2002-12-10 | Nutramax Laboratories, Inc. | Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
US5827874A (en) * | 1995-05-05 | 1998-10-27 | Meyer; Hans | Methods of treating pain and inflammation with proline |
US6255295B1 (en) * | 1996-12-23 | 2001-07-03 | Nutramax Laboratories, Inc. | Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue |
-
2004
- 2004-02-09 US US10/774,951 patent/US20050176807A1/en not_active Abandoned
-
2005
- 2005-02-09 EP EP05713355A patent/EP1713464A2/en not_active Withdrawn
- 2005-02-09 CN CNA2005800044136A patent/CN1917869A/en active Pending
- 2005-02-09 RU RU2006132353/15A patent/RU2006132353A/en not_active Application Discontinuation
- 2005-02-09 BR BRPI0507486-0A patent/BRPI0507486A/en not_active IP Right Cessation
- 2005-02-09 AU AU2005212370A patent/AU2005212370A1/en not_active Abandoned
- 2005-02-09 JP JP2006553259A patent/JP2007522232A/en active Pending
- 2005-02-09 CA CA002554099A patent/CA2554099A1/en not_active Abandoned
- 2005-02-09 WO PCT/US2005/004363 patent/WO2005077356A2/en active Application Filing
-
2006
- 2006-08-02 ZA ZA200606419A patent/ZA200606419B/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB952812A (en) * | 1962-02-01 | 1964-03-18 | Leo Ind Chim Farm Spa | Tetracycline compositions |
US4806525A (en) * | 1987-06-18 | 1989-02-21 | Mavi S.R.L. | Formulation comprising gelatin and glycine for treating the dryness of skin |
EP0652012A1 (en) * | 1989-03-27 | 1995-05-10 | Albert Naito | Combination of sugars with animo acids and other drugs |
US5198465A (en) * | 1991-06-19 | 1993-03-30 | Dioguardi Francesco S | Compositions based on amino acids for preventing and treating precursor deficiencies in the synthesis of collagen |
US20040092498A1 (en) * | 2002-08-16 | 2004-05-13 | David Blakemore | Substituted glycine derivatives for use as medicaments |
Non-Patent Citations (2)
Title |
---|
LI XIANGLI ET AL: "Dietary glycine prevents peptidoglycan polysaccharide-induced reactive arthritis in the rat: Role for glycine-gated chloride channel", INFECTION AND IMMUNITY, vol. 69, no. 9, September 2001 (2001-09-01), pages 5883 - 5891, XP008049369, ISSN: 0019-9567 * |
ZHONG, ZHI ET AL: "L-Glycine: A novel antiinflammatory, immunomodulatory, and cytoprotective agent", CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE , 6(2), 229-240 CODEN: COCMF3; ISSN: 1363-1950, 2003, XP008049352 * |
Also Published As
Publication number | Publication date |
---|---|
EP1713464A2 (en) | 2006-10-25 |
US20050176807A1 (en) | 2005-08-11 |
RU2006132353A (en) | 2008-03-20 |
AU2005212370A1 (en) | 2005-08-25 |
ZA200606419B (en) | 2008-01-30 |
CN1917869A (en) | 2007-02-21 |
WO2005077356A2 (en) | 2005-08-25 |
BRPI0507486A (en) | 2007-07-10 |
JP2007522232A (en) | 2007-08-09 |
CA2554099A1 (en) | 2005-08-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1216080A1 (en) | Compositions and methods for treating or preventing oxalate-related disease | |
BRPI0716354A2 (en) | "composition and method" | |
IL178661A0 (en) | Topical methadone compositions and methods for using the same | |
WO2008060622A3 (en) | Improved methods and compositions for wound healing | |
WO2005077356A3 (en) | Glycine and/or for use in cartilage affecting conditions | |
EP1742640A4 (en) | Methods and compositions for treating diseases and conditions associated with mitochondrial function | |
EP1876332A4 (en) | Direct injection diesel engine | |
GB0413034D0 (en) | Secure workflow engine | |
AR056816A1 (en) | COMPOSITION WITH DOCOSAPENTENOIC ACID | |
EP1737482A4 (en) | Compositions and methods for treating diseases | |
WO2007019550A3 (en) | Composition and method for use in cartilage affecting conditions | |
ZA200707407B (en) | Composition for preventing plant diseases and method for preventing the diseases | |
EP1896050A4 (en) | Lkktet and/or lkktnt peptide compositions and methods | |
EP1801395A4 (en) | Diesel engine | |
PL1651042T3 (en) | Herbicidal composition having the herbicidal effect enhanced, and method for enhancing the herbicidal effect | |
AU2006255829A8 (en) | Improvements in or relating to pasture management | |
ZA200707346B (en) | Combustion method and system | |
EP1964334A4 (en) | System and/or method for bidding | |
WO2008008348A3 (en) | Method and compositions for treating stroke with fever | |
DE602005000845D1 (en) | Water-dispersed acrylic resin composition | |
EP1835143A4 (en) | Direct injection diesel engine | |
WO2006124862A3 (en) | Methods for the treatment of ocular and neurodegenerative conditions in a mammal | |
WO2006009718A3 (en) | Methods for treating or preventing erectile dysfunction or urinary incontinence | |
WO2007061924A3 (en) | Methods of treating cartilage defects | |
EP1851480A4 (en) | Combustion method and system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2554099 Country of ref document: CA Ref document number: 2005212370 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2006/008487 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006/06419 Country of ref document: ZA Ref document number: 200606419 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006553259 Country of ref document: JP Ref document number: 200580004413.6 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 2005212370 Country of ref document: AU Date of ref document: 20050209 Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWP | Wipo information: published in national office |
Ref document number: 2005212370 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005713355 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006132353 Country of ref document: RU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005713355 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0507486 Country of ref document: BR |